Insurance Coverage Lags as Cancer Science, Treatment Move Forward
“Brain cancer” or “H4 G34-mutant”? As knowledge about genetics advances, some doctors say cancers should be defined by their mutations, not the tissues where they manifest.
Drugs
1-20 of 1,312 results
-
-
The Drugs and Devices Have Been on the Market for Years. But FDA-Ordered Studies Still Aren’t Done.
To get drugs and devices out faster, the FDA lets companies conduct studies of safety or efficacy after the products are approved. In many cases, such “postmarket” studies are behind schedule or overdue, records show.
-
3 Common Drugs Older Adults Might Be Overusing
Not all older people need benzodiazepines, antibiotics, or daily aspirin — and taking them can carry increased risks.
By Paula Span -
Watch: Mark Cuban Says You Can’t Fix Healthcare Until Every Price Is Known
With his online pharmacy, Mark Cuban changed how generic drugs are sold — and he has thoughts about how to fix the healthcare system. The billionaire businessman talks to KFF Health News’ Julie Rovner to answer the question: “How Would You Fix It?”
By Julie Rovner and Hannah Norman -
How Much of a Cancer Drug Is Too Much? Patients, Researchers Challenge FDA-Approved Dosages
Patients and researchers point to evidence that many cancer drug dosages are excessive, and that reducing the amount and frequency could save billions of dollars and prevent some of the worst side effects.
By Arthur Allen -
Newsom Promotes Affordable Insulin, but California’s Generic Label Off to a Slow Start
California is the first to launch state-branded insulin as Gov. Gavin Newsom tries to disrupt the pharmaceutical industry. But the new CalRx drug label has been slow to reach pharmacies and patients.
By Angela Hart -
Watch: Why Abortions Are on the Rise Since ‘Roe’ Was Overturned
The way people undergo abortions has changed. This video details five things to know.
By Kate Wells and Hannah Norman -
Watch: GOP Senator Says Trump’s Tariffs Could Mean Safer Drugs — For a Price
Bill Cassidy of Louisiana chairs the Senate’s health committee. In an interview with KFF Health News’ Julie Rovner, he discusses the drug supply, his proposal to defray out-of-pocket costs, and his controversial vote to confirm Robert F. Kennedy Jr. as health secretary.
By Julie Rovner and Hannah Norman -
Readers Share Personal Insights on Deadly Denials and Pregnancy Centers
KFF Health News gives readers a chance to comment on a recent batch of stories.
-
Copay Assistance Is Meant To Defray Patient Drug Costs. Some Insurers Keep It Instead.
Drugmakers provide financial assistance to help patients afford increasingly expensive medications. But some insurers do not count those payments toward a plan’s deductible or out-of-pocket maximum and make patients pay instead.
By Daniel Chang -
Thousands of Medicare Beneficiaries Thought Their Drug Plan Was Free. Then They Lost It.
Thousands of people who had a Medicare drug plan with zero-dollar premiums last year got small premium increases this year — and didn’t know it. They were dropped from their coverage for failing to pay amounts as little as $8, and most can’t get it again until 2027.
By Susan Jaffe -
She Struggled To Get a Lifesaving Drug Even After Insurers Vowed To Help
Margaret Hvatum ended up in the hospital after her insurer denied coverage of a medicine she relies on to boost her immune system. Hvatum got entangled in the preapproval process, which the insurance industry has vowed to improve.
-
A Ban Won’t Stop Abortion Pill Access, Telehealth Providers Say
As a federal court mulls a case that could result in significant restrictions on a pill used in most abortions, providers say they have alternatives to preserve access even in states with bans in place.
By Kate Wells -
Tennessee Pharmacies Sell Potent Ivermectin, Led by Anti-Vaccine Doctor Who’s Taken ‘Bucketloads’
Four years after the Volunteer State enacted the nation’s first law allowing drugstores to sell ivermectin without patient-specific prescriptions, dozens of pharmacies dispense the drug in highly concentrated pills — many with the help of one anti-vaccine physician.
By Brett Kelman and Rachana Pradhan -
Journalists Highlight Medical Neglect in ICE Detention, RFK Jr. Antidepressant Comments
KFF Health News journalists made the rounds on national and local media recently to discuss topical stories. Here’s a collection of their appearances.
-
At a Tennessee Hospital, a Nurse Stole Fentanyl and AI Missed It, State Records Say
Sentri7, drug diversion software powered by artificial intelligence and used at hundreds of U.S. hospitals, did not catch a months-long string of fentanyl thefts in Tennessee in 2025, according to a state document.
By Brett Kelman and Darius Tahir -
Telehealth Booms as Demand for GLP-1s Surges and Questions Mount About Safety, Oversight
Many telehealth companies have emerged in recent years offering easy access to GLP-1 weight loss drugs as demand has exploded. Meanwhile, researchers and doctors are concerned that some of these online companies aren't properly screening or monitoring patients. “It gives a black eye to telemedicine,” one researcher said.
By Lauren Sausser and Maia Rosenfeld -
Trump Bought Stock in Eli Lilly as His Policies Gave the Drugmaker a Big Boost, Documents Show
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
By Darius Tahir -
Efforts To Understand the Nation’s Drugged Driving Problem Stall Under Trump
The data behind alcohol-related traffic deaths is well studied. Less understood is the toll of vehicle deaths involving drugs or a combination of drugs and alcohol. Attempts to fix that have been stymied by federal budget and staffing cuts.
By Jace DiCola -
Trump Bought Stock in Drugmaker as His Government Boosted Its Obesity Drugs
New ethics disclosures show the president invested in Eli Lilly and a company that manufactures injectable devices as his health agencies implemented policies that benefited them.
By Darius Tahir